AMX-883

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameAMX-883
Drug Alias NameAMX-883
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionBromodomain-containing protein 9 degraders
TargetsBromodomain-containing protein 9
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmphista Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmphista Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A